Freeman, TL, Andreaou, C, Sebra, RP, Beaumont, KG, and TH Swartz. 2021. Single-Cell Characterization of Calcium Influx and HIV-1 Infection Using a Multiparameter Optofluidic Platform. Journal of Visualized Experimentation. http://doi.org/10.3791/62632. PMID: 34096922.

 

 

 

 

Soare, AY, Freeman, TL, Min, AK, Malik, HS, Osota, EO, and TH Swartz. 2021. P2RX7 at the host-pathogen interface of infectious diseases. Micro and Molec Biol Rev 85 (1) e00055-20; http://doi.org/10.1128/MMBR.00055-20.

 

 

 

 

 

Del Valle, DM, Kim-Schulze, SK, Hsin-Hui, H, Beckmann, ND, Nirenberg, S, Wang, B, Lavin, Y, Swartz, TH, Madduri, D, Stock, A, Marron, T, Xie, H, Patel, MK, van Oekelen, O, Rahman, A, Kovatch, P, Aberg, H, Schadt, E, Jagannath, S, Mazumdar, M, Charney, A, Firpo-Betancourt, A, Mendu, DR, Jhang, J, Reich, D, Sigel, K, Cordon-Cardo, C, Feldmann, M, Parekh, S, Merad, M, and S Gnjatic. An inflammatory cytokine signature helps predict COVID-19 severity and death. Nature Medicine. http://doi.org/10.1038/s41591-020-1051-9. PMC7274243.

 

 

 

 

Sigel, KM, Swartz, TH, Golden, E, Paranipe, I, Somani, S, Richter, F, De Freitas, JK, Miotto, R, Zhao, S, Polak, P, Mutetwa, T, Factor, S, Mehandru, S, Mullen, M, Cossarini, F, Bottinger, E, Fayad, Z, Merad, M, Ghjatic, S, Aberg, J, Charney, A, Nadkarni, G, Glicksberg, BS. 2020. Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City. Clinical Infectious Diseases. Clinical Infectious Diseases, ciaa880, http://doi.org/10.1093/cid/ciaa880. PMC7337691.

 

 

 

Freeman, TL and TH Swartz. 2020. Purinergic Receptors: Elucidating the Role of These Immune Mediators in HIV-1 Fusion. Viruses; 12, 290. https://doi.org/10.3390/v12030290.

 

 

 

 

 

 

Soare, AY, Malik, HS, Durham, ND, Freeman, TL, Alvarez, RA, Patel, F, Satija, N, Upadhyay, C, Hioe, CE, Chen, BK, and TH Swartz. 2020. P2X1 selective antagonists block HIV-1 productive infection through inhibition of envelope-dependent fusion. J Virol; 94, 6. http://doi.org/10.1128/JVI.01622-19.

 

 

 

 

 

Soare, AY, Durham, ND, Patel, F, Satija, N, Gopal, R, Tweel, B, Hoffman, KW, Upadhyay, C, O’Brien, M, Bhardwaj, N, Lim, JK, Hioe, CE, Chen, BK, and TH Swartz. 2019. P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1β in a human tonsil explant model. J Virol. e01186-18. http://doi.org/10.1128/JVI.01186-18. PMC6288349.

 

 

 

 

 

Arens, Y, Gaisa, M, Goldstone, S, Liu, Y, Wisnivesky, J, Sigel, C, Swartz, TH, Sigel, K. 2019. Risk of invasive anal cancer in HIV-1 infected patients with high-grade anal dysplasia: a population-based cohort study. Dis Colon Rectum. http://doi.org/10.1097/dcr.0000000000001384. PMC6613994.

Liu, STH, Bailey, M, Zhen, A, Saunders-Hao, P, Bassily-Marcus, A, Harding, M, Rana, M, Kohli-Seth, R, Patel, G, Huprikar, S, and TH Swartz. 2018. An electronic antimicrobial stewardship intervention reduces inappropriate parenteral antibiotic therapy. Infection control and hospital epidemiology 39(11), p. 1396-1397. http://doi.org/10.1017/ice.2018.220.

Esposito, AM, Soare, AY, Patel, F, Satija, F, Chen, BK, and TH Swartz. 2018. A high throughput Cre-lox activated viral membrane fusion assay to identify inhibitors of HIV-1 viral membrane fusion. Journal of Visualized Experimentation. J Vis Exp. 183, e58074, http://doi.org/10.3791/58074. PMC6126790.

Liu Y, Gaisa M, Wang X, Swartz TH, Arens Y, Dresser K, Sigel C, Sigel K. 2018. Immune Microenvironments of Anal Cancer Precursors Differ by HIV-serostatus, Affecting Ablation Outcomes. Journal of Infectious Diseases. J Infect Dis. Feb 14;217(5):703-709. http://doi.org/10.1093/infdis/jix454. PMC5853940.

Esposito, A, Swartz, TH, and BK Chen. 2016. A high throughput cre-lox activated HIV membrane fusion assay identifies pharmacological inhibitors of viral entry. Virology. 490:6-16.http://doi.org/10.1016/j.virol.2015.10.013. PMC5019951.

Yu, J, Wilkins, J, Ding, S, Swartz, TH, et al. 2015. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Cell Rep. 13(1):145-56. http://doi.org/10.1016/j.celrep.2015.08.055. PMC4602366.

Swartz, TH, Esposito, AM, Durham, ND, Hartmann, BM, and BK Chen. 2014. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection. J. Virol. http://doi.org/10.1128/JVI.01158-14. PMC4178786.